longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

EASTON BIOPHARMACEUTICALS

688513

51.161.59% ( +0.80 )
Delay Closed: Sep 30, 15:00:00
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 32.58, within the reasonable range, cheaper than 33.67% of the time in the past 3 years, and the industry ranks 76/222, the industry Median 23.81.

32.58xP/E
¥51.16Stock price
¥1.57Earnings per share
32.58xP/E
Stock price¥51.16Earnings per share¥1.57

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
28.97x
Typical range
24.92x–41.43x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 23.81x
011223344

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 23.81x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
600436SHZZPZH
39.35x4.02%¥71.19B
002422SZKELUN PHARMA
35.53x15.33%¥64.98B
600085SHTRT
33.56x7.45%¥32.56B
000739SZAPELOA
37.81x23.79%¥32.14B
600329SHDRTG
32.07x51.62%¥27.20B
600521SHHuahaipharm
38.97x305.56%¥24.47B
002262SZNHWA
20.98x14.76%¥23.02B
002773SZKHPG
20.12x--¥20.08B
600664SHHPGC
36.39x71.43%¥18.64B
603456SHJiuzhou Pharma
24.79x12.93%¥14.67B
605507SHGuobang Pharma
20.03x--¥14.15B
603707SHNKF
27.41x11.11%¥13.23B
002019SZYifan Pharmaceutical
37.77x12.12%¥11.46B
600420SHSHYNDEC
20.64x--¥11.25B
600572SHCONBA
21.95x--¥10.94B
300357SZWolwo Pharma
25.50x18.88%¥10.64B
002626SZKingdomway
37.46x56.36%¥9.84B
688076SHSinopep
39.71x91.51%¥9.43B
688513SHEASTON BIOPHARMACEUTICALS
32.58x0.00%¥9.03B
002332SZXJZY
22.15x5.56%¥8.55B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.